{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:40:32Z","timestamp":1793644832877,"version":"4.5.1"},"reference-count":39,"publisher":"Informa UK Limited","issue":"10","license":[{"start":{"date-parts":[[2020,8,24]],"date-time":"2020-08-24T00:00:00Z","timestamp":1598227200000},"content-version":"unspecified","delay-in-days":1068,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines & Immunotherapeutics"],"published-print":{"date-parts":[[2017,10,3]]},"DOI":"10.1080\/21645515.2017.1345399","type":"journal-article","created":{"date-parts":[[2017,7,14]],"date-time":"2017-07-14T22:09:41Z","timestamp":1500070181000},"page":"2213-2221","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":46,"title":["Assessment of the potential public health impact of Herpes Zoster vaccination in Germany"],"prefix":"10.1080","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7423-0111","authenticated-orcid":false,"given":"Desmond","family":"Curran","sequence":"first","affiliation":[{"name":"GSK , Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desir\u00e9e","family":"Van Oorschot","sequence":"additional","affiliation":[{"name":"GSK , Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6036-424X","authenticated-orcid":false,"given":"Lijoy","family":"Varghese","sequence":"additional","affiliation":[{"name":"GSK , Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Oostvogels","sequence":"additional","affiliation":[{"name":"GSK , Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Mrkvan","sequence":"additional","affiliation":[{"name":"GSK , Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romulo","family":"Colindres","sequence":"additional","affiliation":[{"name":"GSK , Wavre, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"von Krempelhuber","sequence":"additional","affiliation":[{"name":"GSK , M\u00fcnchen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastassia","family":"Anastassopoulou","sequence":"additional","affiliation":[{"name":"GSK , M\u00fcnchen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2017,9,21]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.09.073"},{"key":"cit0002","unstructured":"CDC . Shingles (Herpes Zoster). [accessed  2017 June 15 ]. http:\/\/www.cdc.gov\/shingles\/hcp\/clinical-overview.html"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1086\/421942"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-14-402"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-6109(05)70381-9"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1586\/14737175.7.11.1581"},{"issue":"2","key":"cit0007","first-page":"35","volume":"14","author":"Volpi A","year":"2007","journal-title":"Herpes"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1086\/510206"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-8-37"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-11-173"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-13-359"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-012-0452-1"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-017-0420-9"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa051016"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir970"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.4161\/hv.23412"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501184"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1603800"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1517\/14712598.2016.1134481"},{"key":"cit0020","unstructured":"Le P , \n                     Rothberg M  . How much is it worth to prevent shingles? Using cost-effectiveness analysis to determine value-based pricing of a new herpes zoster vaccine. 38th Annual North American Meeting of the Society for Medical Decision Making 2016. [accessed  2017 June 15 ] https:\/\/smdm.confex.com\/smdm\/2016bc\/webprogram\/Paper10195.html"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiw047"},{"key":"cit0022","unstructured":"Robert Koch Institute . Bericht zur epidemiologie der influenza in deutschland saison 2014\/15. 2015. [accessed  2017 June 15 ]. https:\/\/influenza.rki.de\/Saisonberichte\/2014.pdf"},{"key":"cit0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2016.08.029"},{"key":"cit0024","unstructured":"Public Health England . Herpes zoster (shingles) immunisation programme September 2015 to August 2016: Report for England. 2016. [accessed  2017 June 15 ]. https:\/\/www.gov.uk\/government\/publications\/herpes-zoster-shingles-immunisation-programme-2015-to-2016-evaluation-report"},{"key":"cit0025","doi-asserted-by":"crossref","unstructured":"Varghese L , \n                     Curran D , \n                     Yan S , \n                     Krishnarajah S , \n                     Olivieri A  . Estimating the Potential Public Health Impact of Introducing the HZ\/su Vaccine in the US Population Aged = >50 Years. ID Week. 2015. [accessed  2017 June 15 ]. https:\/\/idsa.confex.com\/idsa\/2015\/webprogram\/Paper52887.html","DOI":"10.1093\/ofid\/ofv133.1477"},{"key":"cit0026","first-page":"42","volume-title":"Public Health Association of Australia - Communicable Disease Control Conference 2015","author":"Varghese L","year":"2015"},{"key":"cit0027","first-page":"A400","author":"Van Oorschot D","year":"2016","journal-title":"Value in Health"},{"key":"cit0028","first-page":"A400","author":"Van Oorschot D","year":"2016","journal-title":"Value in Health"},{"key":"cit0029","volume-title":"Canadian Immunization Conference - 12th, 2016","author":"Van Oorschot D"},{"key":"cit0030","first-page":"13","volume-title":"Canadian Immunization Conference 2016","author":"Johnson KD","year":"2016"},{"key":"cit0031","unstructured":"Federal Statistical Office . (DeStatis \u2013 Statistisches Bundesamt). Values as of 31 Dec 2015. [accessed  2017 June 15 ]. https:\/\/www.destatis.de\/DE\/Publikationen\/Thematisch\/Bevoelkerung\/VorausberechnungBevoelkerung\/BevoelkerungDeutschland2060_5124202159004.pdf?__blob = publicationFile"},{"issue":"4","key":"cit0032","first-page":"193","volume":"151","author":"Schiffner-Rohe J","year":"2009","journal-title":"MMW Fortschr Med Originalien"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.08.018"},{"key":"cit0034","author":"Schmidt-Ott R","journal-title":"J Infect Submitted"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2010.0618"},{"key":"cit0036","unstructured":"Horn J , \n                     Damm O , \n                     Kretzschmar M , \n                     Karch A , \n                     Siedler A , \n                     Ultsch B , \n                     Weidemann F , \n                     Greiner W , \n                     Mikolaczyk R  . Modellierung der Effekte des Varizellen-Impfprogramms in Deutschland. Abschlussbericht, Version 1.2. [accessed  2017 June 15 ]. http:\/\/www.rki.de\/DE\/Content\/Infekt\/Impfen\/Forschungsprojekte\/Varizellen-Impfung\/Abschlussbericht.pdf?__blob = publicationFile"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2014-004833"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1245896"},{"key":"cit0039","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu918"}],"container-title":["Human Vaccines & Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2017.1345399","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T20:52:29Z","timestamp":1600203149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2017.1345399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,21]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10,3]]}},"alternative-id":["10.1080\/21645515.2017.1345399"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2017.1345399","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-03-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-15","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-06-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-09-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}